About us
News
Draupnir Holdings Ltd have officially merged with Nordic Group B.V
We are pleased to announce that as of January 2023, Draupnir Holdings Ltd which incorporates Altacor, ParaPharm Development & Transdermal…
Draupnir Holdings Ltd have officially merged with Nordic Group B.V
Nordic Pharma files submission to health Canada for the marketing authorization of methotrexate autoinjector for treating rheumatoid arthritis in Canada
Canada, March 29, 2022 – NORDIC PHARMA, a SEVER Life Sciences company, announced today the submission of a New Drug…
Nordic Pharma files submission to health Canada for the marketing authorization of methotrexate autoinjector for treating rheumatoid arthritis in Canada
Nordic Pharma has acquired ALTIM® (cortivazol) pre-filled syringe to strengthen their Rheumatology portfolio
Paris, January 2022 – Nordic Pharma is pleased to announce that they have entered into an agreement with SANOFI to…
Nordic Pharma has acquired ALTIM® (cortivazol) pre-filled syringe to strengthen their Rheumatology portfolio
European Commission approves Teysuno in metastatic colorectal cancer
Nordic Pharma announces that on the 24th of January, the European Commission (EC) approved the new indication for Teysuno® (tegafur/gimeracil/oteracil)…
European Commission approves Teysuno in metastatic colorectal cancer
Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
Nordic Pharma has announced that on 16 December 2021, the Committee for Medicinal Products for Human Use (CHMP) adopted a…
Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
Nordic Pharma present at CPhI !
Nordic Pharma will be attending CPhI Worldwide in Milan, Italy from November 9th-11th 2021. We are actively looking for late stage partnering…
Nordic Pharma present at CPhI !
Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
Nordic Pharma AAP is pleased to announce that the Nordixate® Methotrexate Pre-filled Syringe has been issued market authorization by Instituto…
Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
New Headquarters Offices
Both of Nordic Pharma HQs, located in France and in the Netherlands, have recently moved. Nordic Pharma HQ NL has…
Nordimet® PFS and Pen are launched in Chile!
Nordic Pharma Americas, Asia, Pacific are pleased to announce that as of the 15th of April, Nordimet® PFS and Pen are…
Nordimet® PFS and Pen are launched in Chile!
About Our Portfolio